Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) Cost of Revenue (2016 - 2025)

cbdMD's Cost of Revenue history spans 10 years, with the latest figure at $2.0 million for Q4 2025.

  • For Q4 2025, Cost of Revenue rose 17.67% year-over-year to $2.0 million; the TTM value through Dec 2025 reached $7.5 million, up 1.94%, while the annual FY2025 figure was $7.2 million, 3.53% down from the prior year.
  • Cost of Revenue for Q4 2025 was $2.0 million at cbdMD, up from $1.9 million in the prior quarter.
  • Across five years, Cost of Revenue topped out at $4.3 million in Q4 2021 and bottomed at $1.7 million in Q4 2024.
  • The 5-year median for Cost of Revenue is $2.2 million (2023), against an average of $2.5 million.
  • The largest annual shift saw Cost of Revenue skyrocketed 33.35% in 2021 before it plummeted 41.84% in 2022.
  • A 5-year view of Cost of Revenue shows it stood at $4.3 million in 2021, then tumbled by 41.84% to $2.5 million in 2022, then fell by 27.79% to $1.8 million in 2023, then dropped by 5.78% to $1.7 million in 2024, then rose by 17.67% to $2.0 million in 2025.
  • Per Business Quant, the three most recent readings for YCBD's Cost of Revenue are $2.0 million (Q4 2025), $1.9 million (Q3 2025), and $1.8 million (Q2 2025).